|
|
Volumn 60, Issue 13-14, 1997, Pages 1145-1152
|
|
Behavioural evaluation of cholinergic drugs
|
|
Author keywords
agonists; cholinergic drugs; memory; muscarinic receptor
|
|
Indexed keywords
2 ETHYL 8 METHYL 2,8 DIAZASPIRO[4.5]DECANE 1,3 DIONE;
3 (3 METHYL 1,2,4 OXADIAZOL 5 YL) 1 AZABICYCLO[2.2.1]HEPTANE;
3 (3 METHYL 1,2,4 OXADIAZOL 5 YL)QUINUCLIDINE;
3 (6 CHLORO 2 PYRAZINYL)QUINUCLIDINE;
CEVIMELINE;
CHOLINESTERASE INHIBITOR;
L 680648;
L 687306;
METHYLSCOPOLAMINE;
MUSCARINIC AGENT;
MUSCARINIC M1 RECEPTOR AGONIST;
MUSCARINIC M2 RECEPTOR ANTAGONIST;
MUSCARINIC M3 RECEPTOR AGONIST;
MUSCARINIC RECEPTOR;
MUSCARINIC RECEPTOR BLOCKING AGENT;
OXOTREMORINE M;
RECEPTOR SUBTYPE;
SCOPOLAMINE;
UNCLASSIFIED DRUG;
ALZHEIMER DISEASE;
ANIMAL MODEL;
BEHAVIOR;
BRAIN CORTEX;
CHOLINERGIC SYSTEM;
COGNITIVE DEFECT;
CONFERENCE PAPER;
FOREBRAIN;
HUMAN;
LIMBIC SYSTEM;
MEMORY;
MONKEY;
NONHUMAN;
RAT;
RODENT;
WORKING MEMORY;
ALZHEIMER DISEASE;
ANIMALS;
COGNITION;
DISEASE MODELS, ANIMAL;
HUMANS;
MAZE LEARNING;
MEMORY;
MUSCARINIC AGONISTS;
PARASYMPATHETIC NERVOUS SYSTEM;
SCOPOLAMINE;
|
|
EID: 0030898520
PISSN: 00243205
EISSN: None
Source Type: Journal
DOI: 10.1016/S0024-3205(97)00059-3 Document Type: Conference Paper |
|
Times cited : (50)
|
|
References (17)
|
